SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-020104
Filing Date
2018-08-08
Accepted
2018-08-07 19:17:43
Documents
49
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 Q2'18 10-Q snss-10q_20180630.htm 10-Q 1071891
2 EX-3.11 snss-ex311_75.htm EX-3.11 35186
3 EX-31.1 snss-ex311_8.htm EX-31.1 16675
4 EX-31.2 snss-ex312_7.htm EX-31.2 16849
5 EX-32.1 snss-ex321_6.htm EX-32.1 8177
6 GRAPHIC g5cowojnbrsc000001.jpg GRAPHIC 3336
  Complete submission text file 0001564590-18-020104.txt   3709818

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT snss-20180630.xml EX-101.INS 686561
8 XBRL TAXONOMY EXTENSION SCHEMA snss-20180630.xsd EX-101.SCH 37995
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE snss-20180630_cal.xml EX-101.CAL 34024
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE snss-20180630_def.xml EX-101.DEF 102234
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE snss-20180630_lab.xml EX-101.LAB 258649
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE snss-20180630_pre.xml EX-101.PRE 174978
Mailing Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-266-3500
SUNESIS PHARMACEUTICALS INC (Filer) CIK: 0001061027 (see all company filings)

IRS No.: 943295878 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-51531 | Film No.: 18999520
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences